Incorporating NET biomarkers into clinical protocols could enable patient stratification and guide targeted NET-modulating therapiessuch as PAD4 inhibitors, DNase, or antioxidantsin combination with standard-of-care interventions, ultimately improving metabolic and reproductive outcomes
However, because Mounjaro does activate GLP-1 receptors as part of its mechanism of action, it is often grouped with GLP-1-based therapies in clinical discussions and treatment algorithms
Being FDA-approved for diabetes management first in 2022 (Brand name Mounjaro produced by Eli Lilly), tirzepatide received subsequent FDA approval under a Fast Track designation in 2023 (Brand name Zepbound produced by Eli Lily) (32)
Understanding the storage requirements for tirzepatide is essential to ensure the medication remains effective and safe for use
Capsicumproduction, technology, chemistry, and quality